Cardiovascular diseases and insect venom allergy;Kardiovaskuläre erkrankungen und insektengiftallergie

Allergo Journal

Volumn 14, Issue 7 II, 2005, Pages 569-574

  Müller, Ulrich R ^a,b  

^a Spital Bern Ziegler   (Switzerland)

^b Spital Bern Ziegler   (Switzerland)

Author keywords

blocker; ACE inhibitor; Cerebrovascular insult; Epinephrine; Insect venom allergy; Myocardial infarction; Specific immunotherapy

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYMENOPTERA VENOM; INSECT VENOM;

ALLERGIC REACTION; ANAPHYLAXIS; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DISEASE SEVERITY; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; IMMUNOTHERAPY; INSECT ALLERGY; INSECT STING; OUTCOMES RESEARCH; REVIEW;

EID: 30344450085     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Awai LW, Mekori YA. Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication. Ann Allergy 1984; 53: 48-9
2. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973; 52: 259-64
3. Berkelman RL, Finton RJ, Elsea WR. Beta-adrenergic antagonists and fatal anaphylactic reactions to oral penicillin. Ann Intern Med 1986; 104: 134
4. Brown SGA, Blackman EE, Stenlake V, Meddle JR. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume substitution. Emerg Med J 2004; 21: 149-54
5. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986; 14: 17-21
6. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray C, Torp-Pedersen C, Ball S, Pogue J, Moyé L, Braunwald E, for the ACE-Inhibitor Myocardial Infarction Collaborative Croup. Long term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355: 1575-81
7. Foody JM, Farrell MH, Krumholz HM. β-blocker therapy in heart failure: scientific review. JAMA 2002; 287: 883-9
8. Freemantle N, Cleland J, Young P, Mason J, Harrison J. β blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318: 1730-7
9. Hannaway PJ, Hopper CDK. Severe anaphylaxis and drug induced beta-blockade. N Engl J Med 1983; 308: 1536
10. Hepner M J, Ownby DR, Anderson JA, Rowe MS, Sears-Ewald D, Brown EB. Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. J Allergy Clin Immunol 1990; 86: 407-11
11. Horak A, Raine R, Opie LH, Lloyd EA. Severe myocardial ischaemia induced by intravenous adrenalien. Br Med J (Clin Res Ed) 1983; 186: 519
12. Huber C, Hottinger S, Reimers A, Müller U. Anaphylaktische Reaktion demaskiert koronare Herzkrankheit. Schweiz Med Forum 2005; 5: 322-4
13. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, FusterV, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).] Am Coll Cardiol 2001; 38: 2101-13
14. Ingall M, Goldmann G, Page LB. Beta-blockade in stinging insect anaphylaxis. JAMA 1984; 251: 1432
15. Kammerl MC, Schaefer RM, Schweda F, Schreiber M, Riegger GAJ, Krämer BK. Extracorporal therapy with AN68 membranes in combination with ACE inhibition causing severe anaphylactoid reactions: still a current problem? Clin Nephrol 2000; 53: 486-8
16. Kaplan AP, Anderson JA, Valentine MD, Lockey RF, Pierson WE, Zweiman B, Kaliner MA, Lichtenstein LM, Lieberman PL, Settipane GA, Sheffer AL, Yunginger JW. Beta-adrenergic blockers, immunotherapy and skin testing. Position statement. J Allergy Clin Immunol 1989; 84: 129-30
17. Laxenaire MC, Torrens J, Moneret-Vautrin DA. Choc anaphylactoïde mortel chez un malade traité par bêta-bloquants. Ann Fr Anesth Reanim 1984; 3: 453-4
18. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 2003; 3: 313-8
19. Madowitz JS, Schweiger MJ. Severe anaphylactoid reaction to radiographic contrast media. JAMA 1979; 241: 2813-5
20. Mosbech H. Death caused by wasp and bee stings in Denmark 1960-80. Allergy 1983; 38: 195-200
21. Müller U, Stettler R, Hottinger S. Cardiac symptoms during anaphylaxis to Hymenoptera stings. J Allergy Clin Immunol 1989; 83: 230
22. Müller UR. Insect sting allergy: clinical picture, diagnosis and treatment. Stuttgart-New York: Gustav Fischer Verlag, 1990.
23. Müller UR. Fatal course of Vespula venom immunotherapy: pretreatment withdrawal of the beta-blocker may have been involved. Allergy 2003; 58 (Suppl 74): 99-100
24. Müller UR, Haeberli G. Use of β-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 2005; 115: 606-10
25. Oelkers W. Systemische Reaktionen auf Wespenstiche bei Patienten unter ACE-Hemmer-Therapie. Arzneimittelbrief 1994; 28: 39-40
26. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669-77
27. Piscatelli LR, Fox LM. Myocardial injury from epinephrine overdosage. Am J Cardiol 1968; 21: 735-7
28. Pumphrey RSH. Lessons for management of anaphylaxis from a study on fatal reactions. Clin Exp Allergy 2000; 30: 1144-50
29. Rzany B, Jarisch R, Götz M, Rameis H. Adrenalin in der Therapie des anaphylaktischen Schocks: mögliche Nebenwirkungen. Allergologie 1987; 10: 143-8
30. Saff R, Nahhas A, Fink JN. Myocardial infarction induced by coronary vasospasm after self-administration of epinephrine. Ann Allergy 1993; 70: 396-8
31. Sasvary TG, Müller U. Todesfälle an Insektenstichen in der Schweiz 1978 bis 1987. Schweiz Med Wochenschr 1994; 124: 1887-94
32. Schweizerisches Bundesamt für Statistik. Sektion Gesundheit. Todesursachen in der Schweiz 1998. Neuchâtel: Schweizerisches Bundesamt für Statistik, 2004 (available at: http://www.statistik.admin.ch, accessed September 10, 2004)
33. Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004; 113: 837-44
34. Strupler W, Wüthrich B, Schindler C. Prävalenz der Hymenopterengiftallergien in der Schweiz: eine epidemiologische und serologische Studie der SAPALDIA-Stichprobe. Allergo J 1997; 6 (Suppl 1): 7-11
35. TenBrook JA Jr, Wolf MP, Huffman SN, Rosenwasser U, Konstam MA, Salem DN, Wong JB. Should β-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004; 113: 977-82
36. Toogood JH. Beta-blocker therapy and the risk of anaphylaxis. Can Med Assoc J1987; 136: 929-33
37. Tunon-de-Lara JM, Villanueva P, Marcos M, Taytard A. ACE inhibitors and anaphylactoid reactions during venom immunotherapy. Lancet 1992; 340: 908
38. Walter R, Hartmann K, Kuhn M. Anaphylaktoide Reaktionen und ACE-Hemmer: Sind Insektenstiche eine Gefahr für Patienten unter ACE-Hemmer-Therapie? Schweiz Aerzteztg 1998; 79: 289-90
39. Weber-Mani U, Reimers A, Müller U. Zerebraler Infarkt nach Wespengift-induziertem anaphylaktischen Schock. Allergo J 2003; 12 (Suppl 1): S41-2